Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Sanofi confirms sales rep layoffs
It's been rumored for weeks, and now Sanofi-Aventis is confirming. Yes, the French drugmaker will cut jobs at home in France. Details are sketchy, but here's what we know: Sanofi will lay off 700 to 800 sales reps. That's about one-third of the company's domestic sales force. And the cuts will go deeper than expected; union officials had been bracing themselves for 400 to 600 job losses.
Of course, Sanofi is far from alone in cutting back its sales force this spring. Last month, Merck said it's cutting 1,200 sales reps, and in April, Johnson & Johnson announced 400 cuts in sales and marketing. In March, it was Wyeth saying it would slice 1,200 off the sales payroll.
- see the brief for more
Related Articles:
Ranks of sales reps thinning
Merck to cut 1,200 sales reps
1,200 Wyeth reps out of work
J&J laying off 400 in marketing overhaul
Pfizer to axe 2,200 sales jobs in realignment
Comments
J&J is slashing hundreds of jobs as of June 23rd -
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


